Wet Macular Degeneration

Retinal diseases in patients with diabetes pose signicant challenges for health care systems. With a high treatment burden and advances in durable therapies, managed care organizations can optimize patient care by addressing coverage barriers that impact timely treatment with anti-VEGF therapies. This roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.

Wet age-related macular degeneration is a condition that can lead to significant vision loss. It is treated with regular injections, which often work well at preventing vision loss but are a burden to patients with the condition.

View our Market Insights webinar to explore strategies to optimize patient outcomes and manage costs in Wet Age-Related Macular Degeneration